Benitec Biopharma Inc. (BNTC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 03:48PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.05M |
| Enterprise value | -17.32M |
| Trailing P/E | 51.55 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 19.25 |
| Price/book (mrq) | 0.36 |
| Enterprise value/revenue | -230.95 |
| Enterprise value/EBITDA | 0.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.92 |
| 52-week change 3 | -3.21% |
| S&P500 52-week change 3 | 15.23% |
| 52-week high 3 | 9.0100 |
| 52-week low 3 | 1.8600 |
| 50-day moving average 3 | 3.3424 |
| 200-day moving average 3 | 3.5614 |
Share statistics
| Avg vol (3-month) 3 | 15.09k |
| Avg vol (10-day) 3 | 15.07k |
| Shares outstanding 5 | 2.57M |
| Implied shares outstanding 6 | 2.57M |
| Float 8 | 2M |
| % held by insiders 1 | N/A |
| % held by institutions 1 | N/A |
| Shares short (14 Nov 2023) 4 | 33.42k |
| Short ratio (14 Nov 2023) 4 | 3.33 |
| Short % of float (14 Nov 2023) 4 | 1.75% |
| Short % of shares outstanding (14 Nov 2023) 4 | 1.30% |
| Shares short (prior month 12 Oct 2023) 4 | 58.6k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 17 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:17 |
| Last split date 3 | 25 July 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 29 June 2023 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -27,166.67% |
Management effectiveness
| Return on assets (ttm) | -56.39% |
| Return on equity (ttm) | -110.63% |
Income statement
| Revenue (ttm) | 75k |
| Revenue per share (ttm) | 0.04 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | 75k |
| EBITDA | -20.26M |
| Net income avi to common (ttm) | -20.42M |
| Diluted EPS (ttm) | -234.8200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 25.86M |
| Total cash per share (mrq) | 10.05 |
| Total debt (mrq) | 491k |
| Total debt/equity (mrq) | 2.20% |
| Current ratio (mrq) | 5.82 |
| Book value per share (mrq) | 8.76 |
Cash flow statement
| Operating cash flow (ttm) | -18.54M |
| Levered free cash flow (ttm) | -10.65M |
© 2023 Yahoo. All rights reserved.